Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.

× No keyword cloud information.

23 in total

1. Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model.

Authors: A Wittmer; K Khazaie; M R Berger
Journal: Clin Exp Metastasis Date: 1999-07 Impact factor: 5.150

2. Basic principles in preclinical cancer chemotherapy.

Authors: N Brock; J Pohl; B Schneider
Journal: J Cancer Res Clin Oncol Date: 1990 Impact factor: 4.553

3. Oncolytic activity and mechanism of action of a novel L-cysteine derivative, L-cysteine, ethyl ester, S-(N-methylcarbamate) monohydrochloride.

Authors: H N Jayaram; M S Lui; J Plowman; K Pillwein; M A Reardon; W L Elliott; G Weber
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

Review 4. Is the P388 murine tumor no longer adequate as a drug discovery model?

Authors: T H Corbett; F A Valeriote; L H Baker
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

5. Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.

Authors: J E Talmadge; M A Chirigos
Journal: Springer Semin Immunopathol Date: 1985

6. Preclinical antitumor activity of batracylin (NSC 320846).

Authors: J Plowman; K D Paull; G Atassi; S D Harrison; D J Dykes; H J Kabbe; V L Narayanan; O C Yoder
Journal: Invest New Drugs Date: 1988-09 Impact factor: 3.850

7. Synthesis and biological properties of oxazolinodaunorubicin--a new derivative of daunorubicin with a modified daunosamine moiety.

Authors: Malgorzata Lukawska; Joanna Wietrzyk; Adam Opolski; Janusz Oszczapowicz; Irena Oszczapowicz
Journal: Invest New Drugs Date: 2009-08-28 Impact factor: 3.850

8. Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Authors: T H Corbett; M C Bissery; A Wozniak; J Plowman; L Polin; E Tapazoglou; J Dieckman; F Valeriote
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

Review 9. Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials.

Authors: J S Fisherman; B L Osborn; H G Chun; J Plowman; A C Smith; M C Christian; D S Zaharko; R H Shoemaker
Journal: Invest New Drugs Date: 1993-02 Impact factor: 3.850

10. In vivo activity on murine tumors of a novel antitumor compound, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190).

Authors: S Nakaike; T Yamagishi; K Samata; K Nishida; K Inazuki; T Ichihara; Y Migita; S Otomo; H Aihara; S Tsukagoshi
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333